Though no changes were seen in the level of T helper cells in the tumor, the elevation in IFN-γ production by the CD4+ cells suggests a tilt in the balance between the anti-tumorigenic type 1 and the immunosuppressive type 2 helper cells in the TME, in favor of the former. The gene discussed is CD4; the disease is neoplasm.